Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > I am out but when I get home
View:
Post by Oden6570 on May 25, 2021 2:51pm

I am out but when I get home

Going to buy another lot of shares Further MDA states - The Theralase compound is also effective without activation, but on average, its activation results in a 4.2 fold enhancement of Zika virus inactivation, a 12 fold enhancement of influenza H1N1 and an 18.7 fold enhancement of Covid inactivation ! Very very encouraging IMHO
Comment by Yajne on May 25, 2021 11:16pm
Although I'm not quite through TLT's MD&A posted to SEDAR on April 28, I absolutely agree with you Oden6570 that TLT investors need to closely read the MD&A. IMO it essentially includes all information that we have been waiting for in their quarterly newsletter. Why wait, closely read the MD&A posted on SEDAR on April 28, almost a month ago.
Comment by Longholder99 on May 26, 2021 8:12am
Just a thought and you all probably know more about this stuff than me. But perhaps they are being spoken to about big pharm coming on board and are making plans so they arent dealing from a position of weakness innany negotiations. If they havent filed paperwork to finance and go it alone they would be stalled if a deal fell through because they arent willing to just give this away.
Comment by Rumpl3StiltSkin on May 26, 2021 8:28am
Yep, they might(probably) have some really good courters, Li Ka Shing himself? But they have to plan ahead for all outcomes.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250